BIOLOGICAL · Unmapped registry intervention
UV1 synthetic peptide vaccine and GM-CSF
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer
NCT01784913
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
UV1 synthetic peptide vaccine and GM-CSFBIOLOGICAL
Sponsors & collaborators
Ultimovacs ASAlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01784913 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.